Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required
Food and Drug Administration
Description
This grant aims to fund clinical trials that test the effectiveness and safety of products for new uses or labeling changes to meet unmet needs in rare neurodegenerative diseases affecting children and adults. The goal is to support collaborative and innovative trials that will increase approved treatments and positively impact drug development for these rare diseases.
The purpose is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare neurodegenerative diseases for children and adults. Through the support of collaborative, efficient, and/or innovative clinical…
Source
Grant ID
FOR-FD-25-001
Funding Source
Food and Drug Administration
Eligibility
The following categories of applicants are invited to apply:
- For profit organizations other than small businesses
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- State governments
- Native American tribal governments (Federally recognized)
- Special district governments
- Native American tribal organizations (other than Federally recognized tribal governments)
- Small businesses
- City or township governments
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- County governments
- Public housing authorities/Indian housing authorities
- Independent school districts
- Private institutions of higher education
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Public and State controlled institutions of higher education
Awards & Funding
Award Ceiling
$900,000
Award Floor
$650,000
Funding Amount
Discretionary
Links
Similar opportunities
- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)
- Notice of Funding Opportunity (NOFO) for Clinical Trials of Orphan Products
- Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
- Efficient and Innovative Natural History Studies for Rare Diseases